[1] Sontheimer RD,Thomas JR,Gilliam JN.Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.Arch Dermatol,1979,115:1409-1415. [2] 施守义,冯树芳,廖康煌,等.亚急性皮肤型红斑狼疮30例分析研究.临床皮肤科杂志,1985,14:230-234 [3] 张建中,马圣清,景稳心,等.22例SCLE临床和实验室观察.中华皮肤科杂志,1986,19:265-269. [4] 徐速,施守义.SCLE 23例随访观察.临床皮肤科杂志,1990,19:6-8. [5] 惠艳,沈大为.亚急性皮肤型红斑狼疮8例报告.中国皮肤性病学杂志,1995,9:38-39. [6] Tebbe B,Mansmann U,Wollina U,et al.Marker in cutaneous lupus erythematosus indicating systemic involvement.A multicenter study of 296 patients.Acta Derm Venereol,1997,77: 305-308. [7] Lopez-Longo FJ,Monteagudo I,Gonzalez CM,et al.Systemic lupus erythematosus: clinical expression and anti-Ro/SSA response in patients with and without lesions of subacute cutaneous lupus erythematosus.Lupus,1997,6:32-39. [8] Tebbe B,Hoffmann S,Ofanos CE.Course and prognosis of subacute cutaneous lupus erythematosus.A prospective study of 34 patients.Hautarzt,1994,45:690-695. [9] Wasicek,CA,Reichlin M.Clinical and serological difference between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La.J Clin Invest,1982,69: 835-843. [10] Provost TT,Watson R.Anti-Ro(SSA)HLA-DR3-positive women: the interrelationship between some ANA negative,SS,SCLE,and NLE mothers and SS/LE overlap female patients.J Invest Dermatol,1993.100: 14S-20S. [11] Katayama K,Yamamoto T,Otoyama K,et al.Clinical and immunological analysis of annular erythema associated with Sjogren svndrome.Dermatology,1994,189(Suppl):14-17. |